These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4318447)

  • 21. Neuromuscular block after intra-arterially injected acetylcholine. 2. Effects of ACTH treatments as possible detectors of desensitization level in the receptor site.
    Pinelli P; Tonali P; Gambi D
    J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):271-4. PubMed ID: 4350704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)].
    Jurenić D; Jusić A
    Neurologija; 1978; 26(1-4):37-9. PubMed ID: 754038
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
    [No Abstract]   [Full Text] [Related]  

  • 24. Aggravation of myasthenia gravis by erythromycin.
    Absher JR; Bale JF
    J Pediatr; 1991 Jul; 119(1 Pt 1):155-6. PubMed ID: 1648610
    [No Abstract]   [Full Text] [Related]  

  • 25. Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission.
    Namba T; Grob D
    Neurology; 1968 Mar; 18(3):273. PubMed ID: 5689669
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of antibodies against skeletal muscle constituents on muscle function in rats.
    Namba T; Grob D
    Rev Can Biol; 1969 Mar; 28(1):9-18. PubMed ID: 5770982
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems of antibiotic administration in myasthenia gravis].
    Onishi A; Shida K; Kuroiwa Y
    Shinkei Kenkyu No Shimpo; 1971; 15(4):906-10. PubMed ID: 4334475
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of sensitivity to curare in myasthenic disorders using a regionaltechnique.
    Brown JC; Charlton JE
    J Neurol Neurosurg Psychiatry; 1975 Jan; 38(1):27-33. PubMed ID: 1117298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced acetylcholine receptors in myasthenia gravis.
    Drachman DB; Fambrough DM; Satyamurti S
    Trans Am Neurol Assoc; 1973; 98():93-5. PubMed ID: 4361781
    [No Abstract]   [Full Text] [Related]  

  • 30. Streptomycin-induced neuromuscular fatigue in myasthenia gravis.
    Hokkanen E; Toivakka E
    Ann Clin Res; 1969 Nov; 1(3):220-6. PubMed ID: 4313111
    [No Abstract]   [Full Text] [Related]  

  • 31. Anticholinergic and membrane activities of amantadine in neuromuscular transmission.
    Nastuk WL; Su P; Doubilet P
    Nature; 1976 Nov; 264(5581):76-9. PubMed ID: 187945
    [No Abstract]   [Full Text] [Related]  

  • 32. Procainamide---a hazard in myasthenia gravis.
    Drachman DA; Skom JH
    Arch Neurol; 1965 Sep; 13(3):316-20. PubMed ID: 5832267
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the impaired neuromuscular transmission in myasthenia gravis].
    Kruckenberg P; Pontzen W; Sandweg R; Bauer H
    Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
    [No Abstract]   [Full Text] [Related]  

  • 34. Atypical myasthenia gravis. A neurophysiological and pharmacological study.
    Bergmans J; Cleppe D; Diniz P; Rosselle N
    Electromyogr Clin Neurophysiol; 1975 Jul; 15(3):271-7. PubMed ID: 173519
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
    Pagala MK; Tada S; Namba T; Grob D
    Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electromyographic characteristics of lysthenon action on neuromuscular transmission in myasthenia patients].
    Kolomenskaia EA; Sigaev VV; Perel'man LB
    Eksp Khir Anesteziol; 1972; 17(4):71-5. PubMed ID: 4345049
    [No Abstract]   [Full Text] [Related]  

  • 37. Sites of action of gerine diacetate in myasthenia gravis.
    Flacke W; Caviness VS; Samaha F; Schwab RS
    Trans Am Neurol Assoc; 1967; 92():158-62. PubMed ID: 5634017
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuromuscular transmission in myasthenia gravis studied with single fibre electromyography.
    Stålberg E; Ekstedt J; Broman A
    J Neurol Neurosurg Psychiatry; 1974 May; 37(5):540-7. PubMed ID: 4366058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular transmission in thyrotoxicosis.
    Puvanendran K; Cheah JS; Naganathan N; Yeo PP; Wong PK
    J Neurol Sci; 1979 Sep; 43(1):47-57. PubMed ID: 230318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.